EUVIMEDEUVIMED entdecken
Open Access

Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin

Lin-Hai Yan, Zhi-Ning Chen, Li-Li, Jia Chen, Wen-E Wei, Xian-Wei Mo, Yu-Zhou Qin, Yuan Lin, Jian-Si Chen

Oncotarget · 06.01.2026 · 17 (1) · 119-119

DOI: 10.18632/oncotarget.28835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Lin-Hai Yan und 8 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yan, L. H., Chen, Z. N., Li-Li, Chen, J., Wei, W. E., Mo, X. W., Qin, Y. Z., Lin, Y., & Chen, J. S. (2026). Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin. Oncotarget, 17(1), 119-119. https://doi.org/10.18632/oncotarget.28835

Vancouver

Yan LH, Chen ZN, Li-Li, Chen J, Wei WE, Mo XW, et al. Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin. Oncotarget. 2026;17(1):119-119. doi:10.18632/oncotarget.28835

BibTeX
@article{Yan2026,
  author = {Yan, Lin-Hai and Chen, Zhi-Ning and Li-Li and Chen, Jia and Wei, Wen-E and Mo, Xian-Wei and Qin, Yu-Zhou and Lin, Yuan and Chen, Jian-Si},
  title = {Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {119--119},
  doi = {10.18632/oncotarget.28835}
}
Kostenlos starten →